Search Results 11-20 of 38 for ⌚원벳원계열 【위너보증.com / 가입코드 9122】 보증업체 ⌚

  1. Safety and Efficacy Study of MLN0128 in Combination With Exemestane or Fulvestrant in Postmenopausal Women With ER/PR+ Metastatic Breast Cancer - Mayo Clinic

    About this study. This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with ...

  2. ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency - Mayo Clinic

    The purpose of this study (Study INZ701-304 [ADAPT])) is to assess the long-term safety of INZ-701 in patients with ENPP1 Deficiency or ABCC6 Deficiency who ...

  3. https://www.mayoclinic.org/arabic_patient_consumer_web.xml

  4. Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma - Mayo Clinic

    About this study. This partially randomized phase I/II trial studies the side effects and best dose of sapanisertib and to see how well it works compared to ...

  5. A Study to Evaluate the Combination of Binimetinib and Palbociclib in Treating Patients with KRAS and NRAS Mutant Metastatic or Unresectable Colorectal Cancer - Mayo Clinic

    Binimetinib and palbociclib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as TAS- ...

  6. Publications - Peter A. Noseworthy, M.D., M.B.A. - Mayo Clinic

    Sang P, Adel F, Maheshwari A, Mangold K, Attia Z, Cummings P, Davidge-Pitts C, Lopez-Jimenez F, Friedman P, Noseworthy P. Artificial Intelligence Evaluation of ...

  7. Px Code,Supply #,Description,Unit Price 278000026,3643,KIT HEMODIALYSIS CATHETER POLYURETHANE DUAL LUMEN OVER THE WIRE SYMMETRIC TIP 14.5FRX19CM,498.12 ...

  8. A Study of LNK01002 in Patients With Primary (PMF) or Secondary Myelofibrosis (PV-MF, ET-MF) or Acute Myeloid Leukemia - Mayo Clinic

    The purpose of this study is to evaluate safety and tolerability of multi-kinase inhibitor LNK01002 in patients with primary myelofibrosis (MF), or MF due to ...

  9. Alternate Doses and Dosing Schedules of Belantamab Mafodotin for the Treatment of Triple-Class Recurrent and/or Refractory Multiple Myeloma - Mayo Clinic

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in patients ...